Ravi Kane
Ravi Kane
Garry Betty/V Foundation Chair and GRA Eminent Scholar in Cancer Nanotechnology
EBB 5019
404.385.4608
Georgia Tech, School of Chemical & Biomolecular Engineering
Research Interests:
Polyvalency and Biotherapeutics, Nanobiotechnology, Optogenetics
Kane’s research lies at the interface of biotechnology and nanotechnology. His group is designing nanoscale polyvalent therapeutics and working on the molecular engineering of biosurfaces and nanostructures. Kane was previously named by MIT’s Technology Review as one of the TR100 – the top 100 young innovators in the world.
Publications: 
